Navigation Links
National Minority Quality Forum Announces Support for Government Noninterference in Drug Price Negotiations
Date:3/19/2013

WASHINGTON, March 19, 2013 /PRNewswire-USNewswire/ -- The National Minority Quality Forum (The Forum) announces today its support for government noninterference in drug price negotiations for Medicare Part D. A provision of the Social Security Act prohibits the Secretary of Health and Human Services from interfering in the negotiations between drug manufacturers, pharmacies, and sponsors of prescription drug plans (PDPs) involved in Part D of Medicare, or from requiring a particular formulary or price structure for covered Part D drugs.  The Forum continues to support this approach.

Proponents of empowering the Secretary to negotiate drug prices say repealing the non-interference provision will reduce prescription drug cost for Part D. There is no evidence to support their opinion, particularly in light of a Congressional Budget Office (CBO) report. (CBO was created by Congress to provide nonpartisan, objective analysis to inform the legislative process.)  The CBO report states "…modifying the noninterference provision would have a negligible effect on federal spending because we anticipate that under the bill the Secretary would lack the leverage to negotiate prices across the broad range of covered Part D drugs that are more favorable than those obtained by PDPs under current law. Without the authority to establish a formulary or other tools to reduce drug prices, we believe that the Secretary would not obtain significant discounts from drug manufacturers across a broad range of drugs." 

In other words, government interference in drug price negotiations can potentially reduce drug costs only by adding a restrictive, government mandated, national formulary.

Formularies, whether established by the HHS Secretary or by commercial insurers, are inherently discriminatory and anti-consumer. They ignore medical need, ability to pay, genetic variability, culture and gender. They achieve financial objectives by compromising quality and denying care. Centralized price setting is an equally objectionable option. Neither of these approaches to artificially constraining access to care is acceptable to the National Minority Quality Forum. Nor, we believe, are they acceptable to the American healthcare consumer – collectively or individually. 

"The Forum supports a consumer-oriented health care system in which government provides means tested premium support for private insurance," says Gary A. Puckrein , PhD, president and chief executive officer of the National Minority Quality Forum. Government can and should play a critical role in this system by enforcing transparency, arresting fraud and abuse, and guaranteeing the safety and efficacy of medical care. Government should encourage investments that address unmet medical needs and support efforts to find cost-efficient solutions for therapies that currently fail to satisfy consumer demands. Government should not set drug prices, nor should it establish formularies."

The National Minority Quality Forum is a Washington, DC–based not-for-profit, non-partisan, independent research and education organization dedicated to improving the quality of health care that is available for and provided to all populations. Visit our website at www.nmqf.org. Look for us on Facebook (National Minority Quality Forum), and follow us on Twitter (http://www.twitter.com/NMQF).


'/>"/>
SOURCE National Minority Quality Forum
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Research-based Pharmaceutical Industry and International Federation of Red Cross and Red Crescent Societies Join Forces to Prevent Non-Communicable Diseases
2. Watertree Health Rolls Out National Prescription Discount Card Program
3. New National Survey Shows Majority of Americans Confident About Choosing Health Coverage
4. PAREXEL International Provides Update On Share Repurchase Program, Announces A New $50 Million Accelerated Share Repurchase Agreement And A New $50 Million 10b5-1 Trading Plan
5. Results from the 2011 National Survey on Drug Use and Health, Live on the "America by the Numbers" Segment of C-SPANs "Washington Journal"
6. DMH International Selects Beta Partners for TouchPACS
7. HeartWare International, Inc. Announces Pricing of Public Offering of Common Stock
8. HeartWare International, Inc. Announces Public Offering of Common Stock
9. CTIA -The Wireless Association Selects Orthocare Innovations for National Spotlight Featuring Its Cutting-Edge Wireless Technology
10. Guardsman Scientific Lead IP Council to Present at the American College of Cardiology National Meeting
11. The Societe Internationale dUrologie launches SIU Academy, a powerful new resource for urologists.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2017)... International plc (NASDAQ: ENDP ) will announce its second-quarter ... senior management team will host a conference call and webcast before ... The dial-in number to access the call is U.S./ ... is 45397076. Please dial in 10 minutes prior to the scheduled ... of the call will be available from August 8, 2017 at ...
(Date:7/12/2017)... 2017 CarpalAID is a revolutionary new product that relieves ... Carpal tunnel syndrome affects more than 8 million people a ... of men. The common methods of treating CTS are painful surgery, ... braces or gloves. ... CarpalAID is a clear patch worn on the palm ...
(Date:7/11/2017)... , July 11, 2017  Sysmex America, Inc., ... diagnostic testing equipment as well as middleware information ... way to make quality assurance easier and more ... is well known for the innovation that it ... Monitor elevates quality assurance processes to a new ...
Breaking Medicine Technology:
(Date:7/20/2017)... ... ... ChenMed , a leading provider of value-based care for seniors, today announced ... Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family Medicine at the ... for the UVA Health System, brings 30 years of highly relevant experience to his ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended ... The adjustable beds used in such facilities are specially designed to accommodate patients with ... support. , An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM ...
(Date:7/20/2017)... ... July 20, 2017 , ... Vixiar Medical, Inc. , ... systems for monitoring cardiopulmonary diseases, announced today that it has raised seed round ... submissions and fund final engineering and initial production of the Company’s first product, ...
(Date:7/20/2017)... ... July 20, 2017 , ... TCGRx announced ... its existing adherence automation lines. The ATP® Mini and InspectRx® Mini ... TCG’s standard products, but at a size and price point that can help ...
(Date:7/20/2017)... ... July 20, 2017 , ... A budget proposal to switch ... of - living - adjustment (COLA) is a bad deal for older and disabled ... price index (CPI) would grow even more slowly than the conventional one that is ...
Breaking Medicine News(10 mins):